Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

377
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
377
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

612
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
612
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

143
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
143
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

291
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
291
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

724
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
724
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

494
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
494

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Walking Together: Advancing Culturally Grounded Diabetes Care in Indigenous Communities.

Healthcare management forum·2026
Same author

The Barriers and Enablers to Implementing Child and Family Health Hubs for Migrant Families.

International journal of integrated care·2026
Same author

Views of Women and Health Care Providers Regarding Type 2 Diabetes Screening and Preventive Strategies Post Gestational Diabetes: An Interview Study.

Women's health issues : official publication of the Jacobs Institute of Women's Health·2026
Same author

Relationship between hypertensive disorders of pregnancy and postpartum mood and anxiety symptoms: P4 study.

Archives of women's mental health·2026
Same author

Recurrent Syncope and Ventricular Standstill Due to Phase 4 His-Purkinje Block.

JACC. Case reports·2026
Same author

Factors affecting hospital inpatient blood pressure measurement as ranked by a Delphi survey.

Scientific reports·2026

Related Experiment Video

Updated: Dec 1, 2025

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

1.1K

Recognizing Cardiovascular Risk After Preeclampsia: The P4 Study.

Mark A Brown1,2, Lynne Roberts2,3, Anna Hoffman1

  • 1Department of Renal Medicine St George Hospital Sydney New South Wales Australia.

Journal of the American Heart Association
|November 10, 2020
PubMed
Summary

Women with a history of preeclampsia have a higher risk of hypertension postpartum. New blood pressure (BP) guidelines, particularly using 24-hour ambulatory monitoring, can better identify these women for targeted therapy.

Keywords:
blood pressure monitoringcardiovascular riskhigh blood pressurepreeclampsiapregnancy hypertension

More Related Videos

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System
07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System

Published on: May 5, 2018

12.0K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.9K

Related Experiment Videos

Last Updated: Dec 1, 2025

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

1.1K
Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System
07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System

Published on: May 5, 2018

12.0K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.9K

Area of Science:

  • Cardiovascular Medicine
  • Obstetrics and Gynecology
  • Public Health

Background:

  • Preeclampsia significantly increases long-term risks for women, including hypertension, cardiovascular disease, and premature mortality.
  • Postpartum follow-up is crucial for identifying women with elevated blood pressure (BP) after preeclampsia.

Purpose of the Study:

  • To establish the upper limits of normal BP at 6 months postpartum.
  • To determine the frequency of elevated BP in women with prior preeclampsia using these new limits.

Main Methods:

  • Blood pressure (BP) was measured using standard sphygmomanometry, 24-hour ambulatory BP monitoring, and central BP in 302 women with normotensive pregnancies and 90 with preeclampsia.
  • The upper limit of normal BP was defined as mean + 2 standard deviations (SD) for each measurement type.

Main Results:

  • The upper limits of normal BP at 6 months postpartum were 122/79 mm Hg (routine), 115/81 mm Hg (central), and 121/78 mm Hg (24-hour ambulatory).
  • Traditional BP norms identified only 3% of women with prior preeclampsia as hypertensive, while the new limits identified 13-19%.
  • Women with preeclampsia showed higher BMI, left ventricular wall thickness, triglycerides, and HOMA-IR scores, with lower HDL levels.

Conclusions:

  • Clinicians should use lower postpartum BP limits for women with a history of preeclampsia, favoring 24-hour ambulatory BP monitoring.
  • These findings may help define a subgroup of women post-preeclampsia who would benefit from targeted BP-lowering therapies.